HSD17B10
- Aliases
-
- 17-beta-HSD 10
- 17-beta-hydroxysteroid dehydrogenase 10
- 17b-HSD10
- 3-hydroxy-2-methylbutyryl-CoA dehydrogenase
- 3-hydroxyacyl-CoA dehydrogenase type II
- 3-hydroxyacyl-CoA dehydrogenase type-2
- AB-binding alcohol dehydrogenase
- ABAD
- CAMR
- DUPXp11.22
- EC 1.1.1.35,EC 1.1.1.178
- ERAB
- Endoplasmic reticulum-associated amyloid beta-peptide-binding protein
- HADH2
- HCD2
- HSD17B10
- MHBD
- MRPP2
- MRX17
- MRX31
- MRXS10
- Mitochondrial RNase P protein 2
- Mitochondrial ribonuclease P protein 2
- SCHAD
- SDR5C1
- Short-chain type dehydrogenase/reductase XH98G2
- Type II HADH
- XH98G2
- amyloid-beta peptide binding alcohol dehydrogenase
- endoplasmic reticulum-associated amyloid beta-peptide-binding protein
- hydroxyacyl-Coenzyme A dehydrogenase, type II, hydroxyacyl-Coenzyme A dehydrogenase, type II
- hydroxysteroid (17-beta) dehydrogenase 10
- mental retardation, X-linked, syndromic 10
- mitochondrial RNase P subunit 2
- mitochondrial ribonuclease P protein 2
- short chain L-3-hydroxyacyl-CoA dehydrogenase type 2
- short chain dehydrogenase/reductase family 5C, member 1
- short chain type dehydrogenase/reductase XH98G2
- Description
- HSD17B10, hydroxysteroid (17-beta) dehydrogenase 10, is a member of the short-chain dehydrogenase/reductase superfamily. HSD17B10 functions in mitochondrial tRNA maturation and catalyzes the oxidation of a wide variety of fatty acids, alcohols, and steroids. The protein is thought to play a role in the development of Alzheimer's disease. There are several alternatively spliced transcript variants, of which only two have been fully sequenced.
Attributes
- QA State
- Curated
- Type
- Protein
- HGNC Name
- HSD17B10
- Certifications
-
- None
- QA State for Breast
- Under Review
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
- Development and validation of sandwich ELISA microarrays with minimal assay interference.
- Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study.
- Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.